Remi Villenave
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Assessing drug-induced liver injury liabilities in human and animal hepatocytes under static and perfused spheroid culture conditions.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: September 04, 2026
FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 23, 2025
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges.
Journal: Nature reviews. Drug discovery
Published: October 06, 2025
Comparative Analysis of Species-Specific Hepatocyte Function and Drug Effects in a Liver Microphysiological System PhysioMimix LC12 and 96-Well Plates.
Journal: ACS pharmacology & translational science
Published: August 07, 2025
Human Small Intestinal Tissue Models to Assess Barrier Permeability: Comparative Analysis of Caco-2 Cells, Jejunal and Duodenal Enteroid-Derived Cells, and EpiIntestinalTM Tissues in Membrane-Based Cultures with and Without Flow.
Journal: Bioengineering (Basel, Switzerland)
Published: June 30, 2025
An immune competent in vitro model of IL2 induced vascular leakage enables mechanistic insights and evaluation of mitigation strategies.
Journal: Scientific reports
Published: May 02, 2025
Application of new approach methodologies for nonclinical safety assessment of drug candidates.
Journal: Nature reviews. Drug discovery
Published: March 12, 2025
Comparative analysis of Caco-2 cells and human jejunal and duodenal enteroid-derived cells in gel- and membrane-based barrier models of intestinal permeability.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: January 31, 2025
Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessment.
Journal: Drug discovery today
Published: December 20, 2024
Analyzing IL-2-induced vascular leakage with an irAOP as tool.
Journal: Journal of immunotoxicology
Published: December 10, 2024
Opportunities for Microphysiological Systems in Toxicity Testing of New Drug Modalities.
Journal: Annual review of pharmacology and toxicology
Published: September 03, 2024
Last Updated: 09/26/2026